Clinical Trials · NCT02944500
Saxenda: Underlying Mechanisms and Clinical Outcomes
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Enrollment
- 28
- Start date
- Nov 2016
- Locations
- 1 site, United States
- Primary endpoint
- BOLD response to food cues